HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

5- chloro- 2- (5- chlorothiophene- 2- sulfonylamino)- N- (4- (morpholine- 4- sulfonyl)phenyl)benzamide

a soluble guanylyl cyclase activator; structure in first source
Also Known As:
HMR 1766; HMR-1766; HMR1766
Networked: 5 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Berry, Robert E: 1 article (07/2011)
2. Brailey, Jacqueline L: 1 article (07/2011)
3. Fritz, Bradley G: 1 article (07/2011)
4. Montfort, William R: 1 article (07/2011)
5. Hu, Xiaohui: 1 article (07/2011)
6. Walker, F Ann: 1 article (07/2011)
7. Hellstrom, Wayne J G: 1 article (05/2010)
8. Kadowitz, Philip J: 1 article (05/2010)
9. Gur, Serap: 1 article (05/2010)
10. Dumitrascu, Rio: 1 article (10/2009)

Related Diseases

1. Cardiovascular Diseases (Cardiovascular Disease)
2. Renal Insufficiency (Renal Failure)
3. Pulmonary Hypertension (Ayerza Syndrome)
4. Heart Failure
5. Anoxia (Hypoxia)

Related Drugs and Biologics

1. Guanylate Cyclase (Guanylyl Cyclase)
2. BAY 58-2667
3. soluble guanylyl cyclase
4. Nitric Oxide (Nitrogen Monoxide)
5. Heme (Haem)
6. 3- (2- (2,2- dimethylpropylsulfanyl)pyridin- 3- yl)- N- (3- hydroxycyclohexyl)acrylamide